The agency also announced the creation of an advisory panel to improve the way it announces safety worries
and a collaboration with the Veterans Health Administration to track how real patients fare after taking drugs.
Sen. Christopher J. Dodd, (D-Conn.), says that far greater changes are
needed at the agency. Dodd promises to introduce two bills today that would reorganize the F.D.A. and require drug makers to disclose the results of all clinical trials involving humans.
F.D.A. commissioner Dr. Andrew C. von Eschenbach says the initiatives are "merely a step as we continue a process of improvement that will be ongoing."